Current treatment of type II familial hyperlipoproteinemia (essential familial hypercholesterolemia).
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003911:Dextrans / Q000008:administration & dosage; D004035:Diet Therapy; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000235:genetics* / Q000601:surgery / Q000628:therapy*; D007081:Ileostomy; D007275:Injections, Intravenous; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use; D011205:Povidone / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D003911:Dextrans; D009539:Nicotinic Acids; D002784:Cholesterol; D011205:Povidone